|
International clinical studies - a new drug to treat breast cancer
|
Who
|
Patients with breast cancer - locally advanced, recurrent,metastatic
|
|
Medicine
|
Sorafenibwith capecitabine
|
|
Study
|
A multicenter, randomized, double-blind, placebo-controlled,phase III clinical study
|
International clinical studies - a new drug to treat breast cancer
|
Who
|
Patients with breast cancer - locally advanced, recurrent,metastatic
|
|
Medicine
|
Pelletizedproduct
|
|
Study
|
A multicenter, randomized, double-blind, placebo-controlled,phase II clinical trial
|
International clinical studies - a new drug to treat lung cancer
|
Who
|
First-line maintenance therapy for patients with non-small cell lung cancer (NSCLC) in an
advanced stage, patients withprogression and without progression, who had 4 cycles
ofplatinum-based chemotherapy
|
|
Medicine
|
Tarceva
|
|
Study
|
A multicenter, randomized, double-blind, placebo-controlled,Phase 3 clinical trial
|
International clinical studies - supporting new drug for lung cancer
|
Who
|
An important adjunctive therapy in patients with NSCLC who had failed at least two modes of
cancer treatment
|
|
Medicine
|
Pelletized product |
|
Study
|
A multicenter, randomized, double-blind, placebo-controlled,phase II clinical trial
|
International clinical studies - a new drug to treat colon cancer
|
Who
|
Patients with metastatic colorectal cancer with gene K-ras wildtype.
They can be placed in patients whose disease is resistantor re-develop the first-line
chemotherapy in a treatment regimenincluding oxaliplatin. |
|
Medicine
|
2 doses of the combination of cetuximab with irinotecancompared with cetuximab and
irinotecan alone
|
|
Clinical Trials
|
Multicenter clinical trial phase I / II evaluating two doses of
|
International clinical studies - a new drug to treat melanoma
|
Who
|
Patients with unresectable or metastatic melanoma stage III and IV
|
|
Medicine
|
Masitinib / dacarbazine
|
|
Study
|
A multicenter, randomized, double-blind, active-controlled, double-parallel phase 3 clinical
trial
|
International clinical studies - a new drug for the treatment ofbreakthrough pain
|
Who
|
Patients with cancer and breakthroughpain
|
|
Medicine
|
Fentanyl Ethypharm
|
|
Study
|
A multicenter, randomized, double-blind, placebo-controlled,Phase 3 clinical trial
|
A randomized placebo-controlled clinical trial drug FentanylEthypharm for breakthrough pain in
cancer patients.
International clinical studies - a new drug to treat vomiting inchemotherapy
administration
|
Who
|
Patients with highly emetogenicchemotherapy
|
|
Medicine
|
|
|
Study
|
A multicenter, randomized, double-blind
|
The nearest oncology department.
|
